Led by Inas Thomas, MD, the TrialNet team at University of Michigan is dedicated to preventing type 1 diabetes and stopping disease progression by preserving insulin production before and after diagnosis.

Note: As a TrialNet affiliate, University of Michigan is regionally overseen by Indiana University - Riley Hospital for Children. If you reach out to TrialNet, you may be contacted by staff from either institution. 

University of Minnesota is one of eighteen type 1 diabetes TrialNet International Clinical Centers at the forefront of type 1 diabetes research. Led by Antoinette Moran, MD, the TrialNet team at University of Minnesota is dedicated to preventing type 1 diabetes and stopping disease progression by preserving insulin production before and after diagnosis. 

Led by Nina Jain, MD, the TrialNet team at UNC Chapel Hill is dedicated to preventing type 1 diabetes and stopping disease progression by preserving insulin production before and after diagnosis.

Note: As a TrialNet affiliate, UNC Chapel Hill is regionally overseen by Vanderbilt Eskind Diabetes Clinic. If you reach out to TrialNet, you may be contacted by staff from either institution. 

University of Pittsburgh is one of eighteen type 1 diabetes TrialNet International Clinical Centers at the forefront of type 1 diabetes research. Led by Ingrid Libman, MD, PhD, the TrialNet team at University of Pittsburgh is dedicated to preventing type 1 diabetes and stopping disease progression by preserving insulin production before and after diagnosis. Our center is located at the Children's Hospital of Pittsburgh of UPMC.

Led by Henry Rodriguez, MD, the TrialNet team at University of South Florida (USF) is dedicated to preventing type 1 diabetes and stopping disease progression by preserving insulin production before and after diagnosis.

Note: As a TrialNet affiliate, University of South Florida is regionally overseen by University of Florida. If you reach out to TrialNet, you may be contacted by staff from either institution. 

University of Texas Southwestern (UTSW) is one of eighteen type 1 diabetes TrialNet International Clinical Centers at the forefront of type 1 diabetes research. Led by Perrin White, MD, the TrialNet team at UTSW is dedicated to preventing type 1 diabetes and stopping disease progression by preserving insulin production before and after diagnosis.

Led by Zoe Raleigh, MD, the TrialNet team at University of Utah is dedicated to preventing type 1 diabetes and stopping disease progression by preserving insulin production before and after diagnosis.

Note: As a TrialNet affiliate, University of Utah is regionally overseen by Barbara Davis Center for Childhood Diabetes. If you reach out to TrialNet, you may be contacted by staff from either institution. 

Led by Christine Burt Solorzano, MD, the TrialNet team at University of Virginia Health System is dedicated to preventing type 1 diabetes and stopping disease progression by preserving insulin production before and after diagnosis.

Note: As a TrialNet affiliate, University of Virginia Health System is regionally overseen by University of Pittsburgh. If you reach out to TrialNet, you may be contacted by staff from either institution. 

Vanderbilt University Medical Center is one of eighteen type 1 diabetes TrialNet International Clinical Centers at the forefront of type 1 diabetes research. Led by Bill Russell, MD, the TrialNet team at Vanderbilt is dedicated to preventing type 1 diabetes and stopping disease progression by preserving insulin production before and after diagnosis.

Led by Dr. Bryce Nelson, MD, PhD, the TrialNet team at Virginia Commonwealth University is dedicated to preventing type 1 diabetes and stopping disease progression by preserving insulin production before and after diagnosis. 

Note: As a TrialNet affiliate, Virginia Commonwealth University is regionally overseen by Vanderbilt University Medical Center. If you reach out to TrialNet, you may be contacted by staff from either institution.